Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients ; volume:14 ; number:2 ; day:23 ; month:5 ; year:2014 ; pages:1-2 ; date:5.2014
BMC infectious diseases ; 14, Heft 2 (23.5.2014), 1-2, 5.2014
- Urheber
-
Jenabian, Mohammad-Ali
- Beteiligte Personen und Organisationen
-
Kema, Ido
Ramirez, Robert Paulino
Saeed, Sahar
Rollet, Kathleen
Vyboh, Kishanda
Tejada, Jean-Carlos
Gilmore, Norbert
Klein, Marina B.
Routy, Jean-Pierre
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-S2-O16
- URN
-
urn:nbn:de:1111-2016030321366
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jenabian, Mohammad-Ali
- Kema, Ido
- Ramirez, Robert Paulino
- Saeed, Sahar
- Rollet, Kathleen
- Vyboh, Kishanda
- Tejada, Jean-Carlos
- Gilmore, Norbert
- Klein, Marina B.
- Routy, Jean-Pierre
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients